MAIA LABS

MAIA Labs develops ColoMAIA II, an AI colonoscopy assistant that connects to a standard endoscopy tower. It detects suspected lesions during the procedure, records video and images, and generates a structured procedure report that can be exported to hospital EMR/HIS and PACS systems.

Its customers are hospitals and endoscopy units, with physicians as the primary users. The website states that ColoMAIA II is deployed in 30+ hospitals and describes a monthly cost for the product, but it does not detail the pricing or contract model.

The company was founded in 2022 in Brno, Czech Republic, and lists Brno as its address. ColoMAIA II is a CE-marked medical device under the EU MDR, with FDA clearance in progress. The website cites a 2025-2026 multicenter clinical trial and an installation at Mayo Clinic Florida in 2026. The careers page lists three open roles in Brno but states that hiring for all roles is currently paused.

Product: ColoMAIA II, an AI colonoscopy co-pilot with real-time polyp detection, automatic reporting, and EMR/HIS integration.